Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

I Vergote, A du Bois, A Floquet, J Rau, J-W Kim, J M Del Campo, M Friedlander, S Pignata, K Fujiwara, N Colombo, M R Mirza, B J Monk, I Tsibulak, P M Calvert, T J Herzog, L C Hanker, J Meunier, J-Y Lee, A Bologna, M J Carrasco-AlfonsoP Harter